SLC5A2 and heart disorder: However, increased blood ketones are notalways observed with SGLT2 inhibitors’s in preclinical [62] and clinical research [63, 64]and therefore, measurement of circulating ketone bodies and their trajectoriesafter an index event as well as additional biomarkers will certainly play animportant role in further clinical research of cardiac diseases.